About Us | Contact Us | Site Map | Privacy 
CSMG Technologies, Inc.
Stock Quote:
CTGI
  
 
Home > Medical Technology

Live Tissue Bonding Technology

Tissue Welding

The tissue bonding / welding device is a platform technology that bonds and reconnects living soft biological tissue through fusion without the use of foreign matters or conventional wound closing devices such as sutures, staples, sealant, or glues. The technology leaves little or no scar tissue visible to the naked eye after a few months. Unlike other tissue coagulation methods that tend to destroy tissue by charring, searing and necrosis, the tissue welding patented platform technology bonds and reconnects incised tissue and avoids charring, searing and necrosis, using a low heat delivery method aimed at restoration of the normal functions of the live organs and tissue. The smokeless capability of the tissue welding technology has a significant benefit to the medical professional health services provider because current technologies for R F frequency welding or bonding have significant smoke that the carcinogens have been found carry infectious microorganisms from high risk HIV and Hepatitis patients during surgery.

Three Ukraine hospitals are using the technology daily for open and laparoscopic surgical procedures and techniques. The procedures so far have involved the bonding and reconnecting of incised or separated human tissues in the following body areas - nasal septum, intestine, stomach, skin, gall bladder, liver, spleen, blood vessels, nerves, alba linea, uterus, fallopian tube, ovary and testicles - while restoring the normal function of the body organ.

The technology was invented and developed at the internationally renowned "E. O. Paton Institute of Electric Welding", National Academy of Sciences Ukraine headed by Professor B. E. Paton.

CSMG owns the exclusive world rights to the medical device platform technology.

Tissue Bonding /
Welding Technology


Live Tissue Bonding Demonstration
 

 

     
Procedural Photos
Pictured is a lung lobe portion remaining in the body after resection by CSMG Technology's patented tissue welding/bonding technology.
     
The removed lung lobe portion after the tissue welding/bonding process

 

 

CONTACT:

Donald S. Robbins
President and CEO
CSMG Technologies, Inc.
361-887-7546
K. Bruce Jones
770-955-0409

  Home  
   
  Investor Relations
 
  Newsletter  
   
  Press Releases  
   
  Live Biological Tissue Bonding Platform Technology  
  White Paper
Center
New!
 
   
  CO-2 Separator for Landfill Gas  
   
  Oil and Gas Production Equipment  
   
  International Advisory Council Members  
  Accomplishments and Experience  
  Partners, Subsidiaries and Trademarks  
  Board of Directors  
  Corporate Officers  
   
  Paton Institute of Electric Welding  
Powered by WebStrata
 
 

© 1999-2008 CSMG Technologies, Inc. All Rights Reserved.
Corpus Christi, TX USA || Washington, D.C. USA || Atlanta, GA USA || Kiev, Ukraine